Giessen Pulmonary Hypertension in Lung Cancer Registry

Last updated: March 26, 2025
Sponsor: University of Giessen
Overall Status: Active - Recruiting

Phase

N/A

Condition

Stress

Vascular Diseases

Williams Syndrome

Treatment

All lung cancer patients.

Clinical Study ID

NCT04467333
PH in lung cancer registry
  • Ages > 18
  • All Genders

Study Summary

The aim of this study is to investigate the frequency and implications of pulmonary hypertension in lung cancer patients. To do so, data will be collected from all lung cancer patients at the university hospital Giessen. All data will be analyzed for possible hints of pulmonary hypertension as a comorbidity in lung cancer patients. All information will be generated from the regular guidelines based course of treatment and there will be no interventions. This study will serve as a prospective register for all lung cancer patients treated at the university hospital Giessen.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient with lung cancer at the University of Giessen lung Cancer Center.

Exclusion

Exclusion Criteria:

Study Design

Total Participants: 500
Treatment Group(s): 1
Primary Treatment: All lung cancer patients.
Phase:
Study Start date:
June 29, 2020
Estimated Completion Date:
January 29, 2040

Connect with a study center

  • University hospital Giessen

    Gießen, Hessen 35392
    Germany

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.